Table 1.
Epidemiological and clinical characteristics of HIV-infected and HIV-uninfected children with candidiasis diagnoses from 1997 to 2008
| |
HIV-uninfected children |
HIV-infected children |
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| All candidiasis | Non-ICM | ICM | (a)p-value | All candidiasis | Non-ICM | ICM | (a)p-value | (b)p-value | (c)p-value | (d)p-value | |
|
N |
26 |
16 |
10 |
|
141 |
120 |
21 |
|
|
|
|
|
Males # |
10 (38.5) |
8 (50.0) |
2 (20.0) |
0.264 |
70 (49.6) |
56 (46.7) |
14 (66.7) |
0.145 |
0.403 |
1 |
0.041 |
|
Age (years) * |
0.5 (0; 8.7) |
0 (0; 3.2) |
9 (1.5; 11.0) |
0.008 |
7 (1; 11) |
7 (1; 11) |
4 (2; 11) |
0.921 |
0.016 |
<0.001 |
<0.001 |
| Length of stay (days) * | 6.5 (3.2; 10.5) | 5.5 (3.0; 7.5) | 8.5 (7.0; 22.0) | 0.125 | 13 (7; 22) | 12 (7; 22) | 18 (9; 42) | 0.049 | 0.006 | <0.001 | <0.001 |
Values expressed as: (#) Absolute number (percentage); (*) Median (percentile 25; percentile 75).
Abbreviations: ICM, invasive candidiasis mycosis; HIV, Human immunodeficiency virus.
Significance level (p-values): (a), Non-ICM vs. ICM within a group; (b), all candidiasis between groups, (c); Non-ICM between groups, (d), ICM between groups.
Statistically significant differences are shown in bold.